scispace - formally typeset
Search or ask a question
Posted ContentDOI

In - Vivo Conversion of Astrocytes to Neuroblasts in the Injured Spinal Cord

TL;DR: Maryam Lale Ataei Tabriz Medical University: Tabriz University of Medical Sciences Mohammad Karimipour (  karimiportm@tbzmed.ac.ir) and Parviz Shahabi are the authors of this monograph.
Abstract: Maryam Lale Ataei Tabriz Medical University: Tabriz University of Medical Sciences Mohammad Karimipour (  karimipourm@tbzmed.ac.ir ) Tabriz University of Medical Sciences https://orcid.org/0000-0002-6975-4308 Parviz Shahabi Tabriz Medical University: Tabriz University of Medical Sciences Hamid Soltani-Zangbar Tabriz Medical University: Tabriz University of Medical Sciences Maryam Pashaiasl Tabriz Medical University: Tabriz University of Medical Sciences

Summary (3 min read)

Introduction

  • It is shown that the SRY (sex-determining region Y-box 2), also known as Sox2, is a transcription factor that is essential for maintaining self-renewal, or pluripotency, of undifferentiated embryonic stem cells.
  • Astrocytes due to nearness to radial glial cells identity, their high quantity, and the potential to proliferate in the central nervous system, astrocytes could undertake therapeutic interventional approaches including reprogramming.
  • The concept of direct reprogramming is a process in which one mature somatic cell transforms into another mature somatic cell without undergoing an intermediate pluripotent state or progenitor cell type(Ghasemi- Kasman et al. 2015) .

Ethical issue and study design

  • In the current study, 54 adult male Wister rats (weight: 270-300g) were purchased from the animal laboratory and maintained according to the guide line of ethics committee of Tabriz University of Medical Sciences (registered number 95/5-10/7).
  • All animals were housed in a standard condition under a 12h light/dark schedule with enough food and water.
  • In all groups, laminectomy was performed at the T9-T10 vertebral level in the dorsal surface of the spinal cord using the In nite Horizons Impactor with an impact force of 150 (moderate SCI) kdyn (1 dyn=1g⋅cm/s 2=10-5kg⋅m/s 2=10-5 N) by impactor device.
  • Amniotic uid extraction carried out under supervision the gynecologist with using a 22G Needle.
  • In the cultivation period, the medium was changed twice a week, and in the 90% con uence, the cells trypsinized with trypsin-EDTA [0.25%] and centrifuged, and nally, cells pellet re-seeded in DMEM-low glucose media with 15% FBS, 1% penicillin/streptomycin and10 ng/mL bFGF in the optimized condition.

Preparation of CM

  • The MSCs at the 3rd-5rd passage and 90% con uent, were trypsinized and washed with PBS three times, and re-fed with DMEM-low glucose culture medium in serum-free condition for 48 h.
  • Finally, CM was sterilized through 0.22 µm lters and concentrated by freeze-drying processes and was stored at -80 ℃ until use.

Spinal Cord Surgery

  • After deep anesthesia, an adequate level of anesthesia was determined by checking withdrawal to painful stimuli applied to the hind limb.
  • The rats were shifted to the surgical location and via the mask received an iso urane vapor inhalation (3-5%) and oxygen (0.8-1 L/min) to the end of surgical procedure.
  • To prevent infection following SCI, cipro oxacin (350 ml units/days) was injected via IP for one week.
  • After SCI, the bladder sac was discharged manually twice a day for one week.

Transplantation of hAF-MSCs

  • The next, to examine the effect of the hAF-MSCs on endogenous expression of neuroblasts and astrocytes, the MSCs were detached and harvested using 0.25% Trypsin-EDTA.
  • Prior to the transplantation, the number of cells was estimated by counting in a neobar lam and washed by PBS three times.
  • Following SCI, 5×105 cells per 5µl PBS were transplanted to the proximal, central, and distal parts of the lesion site using a capillary glass needle through a Hamilton syringe.
  • For immunosuppression, the rats received cyclosporine (1 mg/100 g body weight) two days before cell transplantation until the end of the experiment (Springer et al. 2018 ).

Injection of the exogenous human astrocytes

  • In the next series of experiments, the authors decided to investigate the effect of the MSCs and their CM on astrocyte reprogramming and converting the human astrocytes to neuroblasts.
  • To this end, the human astrocytes (Cell line 1321N1) were injected focally into the lesion site of the spinal cord concomitantly with transplantation of MSCs and infusion of CM.

Tissue preparation and immuno uorescence staining

  • For immuno uorescence examinations, animals were sacri ced two weeks after SCI by ketamine (100mg/kg) and xylazine (5mg/kg) overdose.
  • The rats were transcardially perfused with normal saline (NaCl 9%) and 4% paraformaldehyde, respectively.
  • The animal's spinal cord was carefully removed and post-xed overnight with 4% paraformaldehyde solution.

Statistical analysis

  • One-way analysis of variance and post hoc.
  • Tukey tests were performed to detect the statistically signi cant difference between groups.
  • P<0.05 was considered as statistically signi cant.
  • All the statistics presented in the article were analyzed and drawn using Graph Pad Prism (version 6.01; Graph Pad Software, CA, USA).

MSCs secreted the SOX2 protein in the CM

  • This analysis showed that the Sox2 protein was observed in the 32 folds concentrated CM.
  • The results from this panel showed that the MSCs after two weeks of transplantation promoted the level of DCX expression and suppressed the rate of GFAP marker.
  • In general, these data indicate the MSCs through juxtacrine and paracrine pathways could promote the neuroblasts and induce neurogenesis, as well as, diminish the astrocytes in the SCI and nally suppress gliosis and glial scar formation.
  • MSCs and CM could increase the number of neuroblasts relative to the (SCI +Astrocytes + DMEM) group (p<.001, p<.05) respectively .
  • Moreover, presented data showed that MSCs in comparison to CM could raise the functional recovery score more than the CM(p<.05) .

Discussion

  • Astrocytes in large quantities have been distributed throughout the CNS and provide essential factors and desire microenvironment for optimal neural tissue structure and function in a healthy condition (Sofroniew and Vinters 2010) .
  • Regardless of these ndings, astrocyte-derived neurons have not identi ed around the injured area in both the brain and spinal cord (Ohori et al.
  • Therefore, nding new and effective therapeutic strategies including reprogramming and neurogenesis promotion is a challenging and debate subject in the regenerative medicine eld.
  • According to previous evidence, transcription factor Sox2 could be su cient to converting endogenous differentiated astrocytes into neuroblasts and also mature neurons in the adult spinal cord with different severity of the injury (Su et al. 2014a ).
  • In conclusion, the results of the present research point out the protective and regenerative potential of MSCs in the SCI through reprogramming astrocytes to neuroblasts by mediating juxtacrine activity and paracrine effects.

Declarations

  • Author Contributions M.PA and P.SH designed and supervised the whole study.
  • M.K prepared and wrote the manuscript and analyzed data.
  • M.A performed the experiments and involved in data acquisition.

Did you find this useful? Give us your feedback

Content maybe subject to copyright    Report

Page 1/17
In - Vivo
Conversion of Astrocytes to Neuroblasts in
the Injured Spinal Cord
Maryam Lale Ataei
Tabriz Medical University: Tabriz University of Medical Sciences
Mohammad Karimipour ( karimipourm@tbzmed.ac.ir )
Tabriz University of Medical Sciences https://orcid.org/0000-0002-6975-4308
Parviz Shahabi
Tabriz Medical University: Tabriz University of Medical Sciences
Hamid Soltani-Zangbar
Tabriz Medical University: Tabriz University of Medical Sciences
Maryam Pashaiasl
Tabriz Medical University: Tabriz University of Medical Sciences
Research Article
Keywords: Spinal cord injury, MSCs, Astrocyte, Neuroblast, Reprogramming
Posted Date: April 26th, 2021
DOI: https://doi.org/10.21203/rs.3.rs-362556/v1
License: This work is licensed under a Creative Commons Attribution 4.0 International License.
Read Full License

Page 2/17
Abstract
Direct astrocyte reprogramming to neural progenitor cells and promotion of neurogenesis is considered
as an alternative approach to replace the lost neurons in the spinal cord injury(SCI). Herein, we used the
human amniotic uid mesenchymal stem cells (hAF-MSCs) and their conditioned medium (CM), to
investigating their ability to reprogramming astrocytes to neuroblasts following SCI. 54 adult rats were
randomly divided into 9 groups (n = 6), included: Control, SCI, (SCI + DMEM), (SCI + CM), (SCI+ MSCs),
(SCI + Astrocyte), (SCI + Astrocyte + DMEM), (SCI+ Astrocyte+ CM) and SCI+ Astrocyte+ MSCs).
Following laminectomy and SCI induction, DMEM, CM, MSCs and Astrocytes were injected. Wester-blot
was performed to explore the levels of the Sox2 protein in the MSCs-CM. The immunouorescence
staining against DCX and GFAP was done. Finally, Basso-Beattie-Brenham (BBB) locomotor test was
conducted to assess the neurological outcomes. Our results showed that the MSCs through juxtacrine
and paracrine mechanisms induced the promotion of the endogenous neuroblasts and the decline of
astrocytes. Moreover, in the present research, MSCs and CM could convert the transplanted human
astrocytes to neuroblasts in the spinal cord injury. Taken together, our data indicate the MSCs via
juxtacrine and paracrine pathways could direct the spinal cord endogenous neural stem cells(NSCs) to
the neuroblasts lineage rather than astrocytes as well as induce reprogramming. Ultimately, MSCs could
reverse the neurobehavioral decit in the SCI. The striking output in our study was the capability of the
MSCs in the reprogramming of the astrocytes to neuroblasts via juxtacrine and paracrine pathways in the
In-vivo
condition.
Introduction
Spinal cord injury (SCI) is damage to the spinal cord and a complex neurological condition that resulted
in irreversible neuronal loss, glial scar formation, axonal injury, disruption of the myelin sheath and neural
tracts and long-lasting disability and in some cases leads to permanent functional decits in
mammals(Su et al. 2014b; Higuchi et al. 2019; Abolhasanpour et al. 2019). Following SCI, astrocytes
proliferate and migrate into the surrounding milieu and generate glial scar and undesirable
microenvironment (Wang et al. 2016). The research demonstrated that the astrocytes and NG2 (Pre-
oligodrocytes), as a result of reprogramming could convert to neuroblast and neurons in the spinal cord
and brain (Wang et al. 2016). It is shown that the SRY (sex- determining region Y-box 2), also known as
Sox2, is a transcription factor that is essential for maintaining self-renewal, or pluripotency, of
undifferentiated embryonic stem cells. Sox2 has a critical role in the maintenance of embryonic and
neural stem cells and also it is crucial for directing neural differentiation (Zhang and Cui 2014; Mercurio
et al. 2019; Rodriguez-Jimenez et al. 2016). Sox2 can mediated reprogramming of astrocytes to DCX +
neuroblasts and in this context, Sox2 can help to treat SCI by converting glial cells to neurons nally
mature neurons (Wang et al. 2016; Rodriguez-Jimenez et al. 2016). Doublecortin (DCX) is a microtubule-
associated protein expressed by neuronal precursor cells and immature neurons in embryonic and adult
cortical structures and considered as a marker of developing neural progenitor cells (Karimipour et al.
2019; Nasrolahi et al. 2019). Astrocytes due to nearness to radial glial cells identity, their high quantity,

Page 3/17
and the potential to proliferate in the central nervous system, astrocytes could undertake therapeutic
interventional approaches including reprogramming. (Sun et al. 2019). Recent advancements in the eld
of direct in vivo reprogramming showed the generation of functional neurons from reactive glial cells in
the repair of the brain (Li and Chen 2016; Guo et al. 2014). The concept of direct reprogramming is a
process in which one mature somatic cell transforms into another mature somatic cell without
undergoing an intermediate pluripotent state or progenitor cell type(Ghasemi-Kasman et al. 2015).
Transplantation stem cells including MSCs and olfactory ensheathing cells (OECs) in SCI could lead to
increase of neuroprotective molecules and reprogramming of astrocytes into neuroblasts which could
survive and develop into mature neurons (Sabapathy et al. 2017; Sun et al. 2019). In this context, MSCs
by secretion of the essential materials for neuroprotection such as growth factors, cytokines, and
neurotrophic factors, could induce the replacement of lost neuronal cells, remyelination of axons,
angiogenesis, and decline of inammatory responses(Oh and Jeon 2016; Shahrezaie et al. 2017). MSCs
could harvest from different sources including adipose derived tissue, bone marrow, Umbilical Cord
Wharton's Jelly, amniotic membrane and amniotic uid mesenchymal stem cells (hAF-MSCs) and so on
(Gabel et al. 2017; Oh and Jeon 2016). In spite of the plethora of studies and experiments regarding the
evaluation of the functional ecacy of the MSCs in the SCI, the election of the effective source of the
MSCs is one of the challenging issues in the scientic community (Gabel et al. 2017). But recent studies,
suggest that (hAF-MSCs) could account into consideration in the SCI because of the amnion origin from
the epiblast layer as a pluripotent and undifferentiated structure in the embryo(De Coppi et al. 2007;
Antonucci et al. 2014). These cells routinely gained during amniocentesis which is done in the second
trimester and express embryonic and pluripotency markers for instance Oct4, Nanog and Sox2 (Aziz et al.
2019; Gholizadeh-Ghaleh Aziz et al. 2019; Dziadosz et al. 2016; Maraldi et al. 2014; Saito et al. 2012).
Amniotic uid derived- MSCs relative to other sources have high proliferative and regenerative potential
as well as they maintain pluripotency features, and remain without alteration after continuous passages
(Maraldi et al. 2014; Aziz et al. 2016). MSCs during cell culture can secrete paracrine factors in the form
of conditioned medium (CM) (Osugi et al. 2012; Cantinieaux et al. 2013). CM contains metabolites,
growth factors, extracellular matrix proteins, cytokines and anti-inammatory agents which are secreted
into the medium by the cultured cells. (Cantinieaux et al. 2013; Pawitan 2014). Sox2 which is available in
hAF-MSCs-CM is the essential factor for the transform endogenous spinal astrocytes to neuroblasts (Su
et al. 2014b; Zhang and Cui 2014). In this Perspective, we investigated the eciency of the hAF-MSCs
and their CM in the reprogramming of the astrocytes to neuroblasts through juxtacrine and paracrine
mechanisms as well as functional behavior following the SCI.
Materials And Methods
Ethical issue and study design
In the current study, 54 adult male Wister rats (weight: 270-300g) were purchased from the animal
laboratory and maintained according to the guide line of ethics committee of Tabriz University of Medical
Sciences (registered number 95/5-10/7). All animals were housed in a standard condition under a 12h
light/dark schedule with enough food and water. The rats were randomly divided in to 9 groups (six rats

Page 4/17
per group), these nine groups included:Control,SCI, (SCI + DMEM, IP), (SCI + CM, IP), (SCI + MSCs,
Focally), (SCI + Astrocyte), (SCI + Astrocyte+ DMEM, IP), (SCI + Astrocyte+ CM, IP) and SCI + Astrocyte+
MSCs). In all groups, laminectomy was performed at the T9–T10 vertebral level in the dorsal surface of
the spinal cord using the Innite Horizons Impactor with an impact force of 150 (moderate SCI) kdyn (1
dyn=1gcm/s 2=10-5kgm/s 2=10-5 N) by impactor device.
hAF-MSCs isolation, cultivation and characterization
Briey, isolation of hAF-MSCs was done undergoing amniocentesis for the routine karyotype screening of
about 5 ml of amniotic uid samples from eight mothers in Al-Zahra hospital (Tabriz, Iran). Prior to the
amniocentesis, patients written informed consent for donating amniotic uid samples voluntarily for this
research. Amniotic uid extraction carried out under supervision the gynecologist with using a 22G
Needle. After sending the samples to the desired laboratory, samples were centrifuged at 450 g for 10
minutes, next the settled pellet was washed twice by PBS (Gibco; Thermo Fisher Scientic, Darmstadt,
Germany). Then, the cells transferred in 6 well plates with AmnioMAX II Complete Medium (Gibco, cat#
11269) for 1-2 weeks in condition 37°C and 5% CO2. In the cultivation period, the medium was changed
twice a week, and in the 90% conuence, the cells trypsinized with trypsin-EDTA [0.25%] (Gibco) and
centrifuged, and nally, cells pellet re-seeded in DMEM-low glucose media with 15% FBS, 1%
penicillin/streptomycin and10 ng/mL bFGF in the optimized condition. The phenotype prole of the hAF-
MSCs was examined by ow cytometry analysis. For this purpose, the cells at passage 3-5 were
trypsinzed and two times washed with PBS and centrifuge at 1500 RPM for 3 min, then, the cell pellets
were stained with antibodies including CD 105 (Catalog No. 1p-298-To25 Exbio), CD 73 (Catalog No.
561260 BD Biosciences) antibodies as mesenchymal stem cell markers and CD 45 (Catalog No. 1F-222-
T025 Exbio), CD 14 (Catalog No. 12-0149-42 eBioscience) as hematopoietic stem cell markers) with
dilution 1/30 in the PBS for 20 min on ice.
Preparation of CM
The MSCs at the 3rd-5rd passage and 90% conuent, were trypsinized and washed with PBS three times,
and refed with DMEM-low glucose culture medium in serumfree condition for 48 h. Then, CM was
harvested and centrifuged at 450g for 10 min up to eliminate free-oating cells. Finally, CM was sterilized
through 0.22 µm lters and concentrated by freeze-drying processes and was stored at -80 until use.
Western blot
CM was collected from MSCs culture and was sterilized by 0.22 mm lters, then CM was concentrated 2,
4, 8, 16 and 32 folds by freeze dryer device. Sox2 (Sex determining region Y-box 2) secreted by HAF-MSCs
into MSCs-CM, was measured using western blot analysis.
Human astrocyte culture
Human astrocytes (line 1321N1) (Ghasemi-Kasman et al. 2015) were purchased from Pasteur Institute of
Iran and cultured in DMEM low glucose medium with 10% FBS and 1% penicillin/streptomycin. This

Page 5/17
medium was changed twice in a week.
Spinal Cord Surgery
The rats were anesthetized by inhalation of 5% isourane and oxygen (1 L/min) in a closed space. After
deep anesthesia, an adequate level of anesthesia was determined by checking withdrawal to painful
stimuli applied to the hind limb. The rats were shifted to the surgical location and via the mask received
an isourane vapor inhalation (3-5%) and oxygen (0.8-1 L/min) to the end of surgical procedure. Briey,
animals under anesthesia conditions, their back was shaved and in the midline, the skin s incision was
performed around 2cm, and in order to laminectomy, Paravertebral muscles were cut up on the T9-T11
spinal processes, and with the dental drill, a hole of 1.5 mm diameter was made in the vertebral arch of
T10 as far as dura mater could be seen. Then, using the Horizons Impactor, animals received a force of
150-kilodyne (moderate SCI) on the targeted spinal cord segments, subsequently, the muscles and skin
were closed. Also for bilateral injury, transverse process of the rats throughout the surgery and injury xed
by a clamp. To prevent infection following SCI, ciprooxacin (350 ml units/days) was injected via IP for
one week. After SCI, the bladder sac was discharged manually twice a day for one week.
Infusion of MSCs- CM
In order to explore the effect of the CM on the rate expression of the endogenous neuroblasts and
astrocytes, 500 µl of CM, following SCI was infused through intraperitoneal (IP) per day for 7 days.
Transplantation of hAF-MSCs
The next, to examine the effect of the hAF-MSCs on endogenous expression of neuroblasts and
astrocytes, the MSCs were detached and harvested using 0.25% Trypsin-EDTA. Prior to the
transplantation, the number of cells was estimated by counting in a neobar lam and washed by PBS three
times. Following SCI, 5×105 cells per 5µl PBS were transplanted to the proximal, central, and distal parts
of the lesion site using a capillary glass needle through a Hamilton syringe. For immunosuppression, the
rats received cyclosporine (1 mg/100 g body weight) two days before cell transplantation until the end of
the experiment(Springer et al. 2018).
Injection of the exogenous human astrocytes
In the next series of experiments, we decided to investigate the effect of the MSCs and their CM on
astrocyte reprogramming and converting the human astrocytes to neuroblasts. To this end, the human
astrocytes (Cell line 1321N1) were injected focally into the lesion site of the spinal cord concomitantly
with transplantation of MSCs and infusion of CM.
Tissue preparation and immunouorescence staining
For immunouorescence examinations, animals were sacriced two weeks after SCI by ketamine
(100mg/kg) and xylazine (5mg/kg) overdose. The rats were transcardially perfused with normal saline

References
More filters
Journal ArticleDOI
TL;DR: MSC-CdM promotes the resolution of LPS-induced lung injury by attenuating lung inflammation and promoting a wound healing/anti-inflammatory M2 macrophage phenotype in part via IGF-I.
Abstract: Mortality and morbidity of acute lung injury and acute respiratory distress syndrome remain high because of the lack of pharmacological therapies to prevent injury or promote repair. Mesenchymal stem cells (MSCs) prevent lung injury in various experimental models, despite a low proportion of donor-derived cell engraftment, suggesting that MSCs exert their beneficial effects via paracrine mechanisms. We hypothesized that soluble factors secreted by MSCs promote the resolution of lung injury in part by modulating alveolar macrophage (AM) function. We tested the therapeutic effect of MSC-derived conditioned medium (CdM) compared with whole MSCs, lung fibroblasts, and fibroblast-CdM. Intratracheal MSCs and MSC-CdM significantly attenuated lipopolysaccharide (LPS)-induced lung neutrophil influx, lung edema, and lung injury as assessed by an established lung injury score. MSC-CdM increased arginase-1 activity and Ym1 expression in LPS-exposed AMs. In vivo, AMs from LPS-MSC and LPS-MSC CdM lungs had enhanced expression of Ym1 and decreased expression of inducible nitric oxide synthase compared with untreated LPS mice. This suggests that MSC-CdM promotes alternative macrophage activation to an M2 “healer” phenotype. Comparative multiplex analysis of MSC- and fibroblast-CdM demonstrated that MSC-CdM contained several factors that may confer therapeutic benefit, including insulin-like growth factor I (IGF-I). Recombinant IGF-I partially reproduced the lung protective effect of MSC-CdM. In summary, MSCs act through a paracrine activity. MSC-CdM promotes the resolution of LPS-induced lung injury by attenuating lung inflammation and promoting a wound healing/anti-inflammatory M2 macrophage phenotype in part via IGF-I.

285 citations


Additional excerpts

  • ...Several previous studies have used CM in various disorders like skin wounds (Chen et al. 2008), CNS (Teixeira et al. 2014), hepatic transplant (Du et al. 2013), acute lung injury (Ionescu et al. 2012), and chronic kidney diseases (van Koppen et al. 2012)....

    [...]

Journal ArticleDOI
TL;DR: Recent findings concerning the involvement of Sox2 in pluripotency, somatic cell reprogramming and neural differentiation as well as the molecular mechanisms underlying these roles are reviewed.
Abstract: Sex determining region Y-box 2 (Sox2), a member of the SoxB1 transcription factor family, is an important transcriptional regulator in pluripotent stem cells (PSCs). Together with octamer-binding transcription factor 4 and Nanog, they co-operatively control gene expression in PSCs and maintain their pluripotency. Furthermore, Sox2 plays an essential role in somatic cell reprogramming, reversing the epigenetic configuration of differentiated cells back to a pluripotent embryonic state. In addition to its role in regulation of pluripotency, Sox2 is also a critical factor for directing the differentiation of PSCs to neural progenitors and for maintaining the properties of neural progenitor stem cells. Here, we review recent findings concerning the involvement of Sox2 in pluripotency, somatic cell reprogramming and neural differentiation as well as the molecular mechanisms underlying these roles.

271 citations


"In - Vivo Conversion of Astrocytes ..." refers background in this paper

  • ...Sox2 which is available in hAF-MSCs-CM is the essential factor for the transform endogenous spinal astrocytes to neuroblasts (Su et al. 2014b; Zhang and Cui 2014)....

    [...]

  • ...Sox2 has a critical role in the maintenance of embryonic and neural stem cells and also it is crucial for directing neural differentiation (Zhang and Cui 2014; Mercurio et al. 2019; Rodriguez-Jimenez et al. 2016)....

    [...]

Journal ArticleDOI
TL;DR: The targets and mechanisms of BM-MSC mediated neuroprotection are discussed, which offer significant practical advantages over other types of stem cells since they can be obtained from the adult BM and can be easily cultured and expanded in vitro under GMP conditions displaying a very low risk of malignant transformation.

206 citations


"In - Vivo Conversion of Astrocytes ..." refers background in this paper

  • ...Li H, Chen G (2016) In vivo reprogramming for CNS repair: regenerating neurons from endogenous glial cells....

    [...]

  • ...Current Drug Targets-CNS & Neurological Disorders 4 (1):41-50 32....

    [...]

  • ...In response to any CNS damage, they are activated, proliferated, migrated to the lesion site, and participate in glial scar formation (Sofroniew 2009; Yiu and He 2006; Buffo et al. 2008)....

    [...]

  • ...Sun X, Tan Z, Huang X, Cheng X, Yuan Y, Qin S, Wang D, Hu X, Gu Y, Qian W-J (2019) Direct neuronal reprogramming of olfactory ensheathing cells for CNS repair....

    [...]

  • ...A plethora of studies has shown that the activated astrocytes in CNS injuries could be isolated and cultivated in vitro cultivation and produce neurospheres with the capability of a generation of neurons, astrocytes, and oligodendrocytes....

    [...]

Journal ArticleDOI
TL;DR: It is demonstrated that endogenous neural progenitors can be manipulated to replace neurons and oligodendrocytes lost to insults in the injured spinal cord.
Abstract: Neurons and oligodendrocytes are highly vulnerable to various insults, and their spontaneous replacement occurs to only a limited extent after damage in the adult spinal cord. The environment of injured tissue is thus thought to restrict the regenerative capacity of endogenous neural stem/progenitor cells; strategies for overcoming such restrictions remain to be developed. Here, we combined growth factor treatment and genetic manipulation to stimulate neurogenesis and oligodendrogenesis by endogenous progenitors in vivo. The recombinant retrovirus pMXIG, which was designed to coexpress green fluorescent proteins (GFPs) and a neurogenic/gliogenic transcription factor, was directly injected into the injured spinal cord parenchyma to manipulate proliferative cells in situ. We found that cells expressing Olig2, Nkx2.2, and NG2 were enriched among virus-infected, GFP-positive (GFP+) cells. Moreover, a fraction of GFP+ cells formed neurospheres and differentiated into neurons, astrocytes, and oligodendrocytes in vitro, demonstrating that GFP retroviruses indeed infected endogenous neural progenitors in vivo. Neuronal differentiation of control virus-infected cells did not occur at a detectable level in the injured spinal cord. We found, however, that direct administration of fibroblast growth factor 2 and epidermal growth factor into lesioned tissue could induce a significant fraction of GFP-labeled cells to express immature neuronal markers. Moreover, retrovirus-mediated overexpression of the basic helix-loop-helix transcription factors Neurogenin2 and Mash1, together with growth factor treatment, enhanced the production and maturation of new neurons and oligodendrocytes, respectively. These results demonstrate that endogenous neural progenitors can be manipulated to replace neurons and oligodendrocytes lost to insults in the injured spinal cord.

200 citations


"In - Vivo Conversion of Astrocytes ..." refers background in this paper

  • ...Regardless of these ndings, astrocyte-derived neurons have not identi ed around the injured area in both the brain and spinal cord (Ohori et al. 2006; Buffo et al. 2008; Buffo et al. 2005)....

    [...]

Journal ArticleDOI
27 Aug 2013-PLOS ONE
TL;DR: Results support the paracrine-mediated mode of action of BMSCs and raise the possibility to develop a cell-free therapeutic approach, and show that, in vitro, BMSC-conditioned medium (B MSC-CM) protects neurons from apoptosis, activates macrophages and is pro-angiogenic.
Abstract: Spinal cord injury triggers irreversible loss of motor and sensory functions. Numerous strategies aiming at repairing the injured spinal cord have been studied. Among them, the use of bone marrow-derived mesenchymal stem cells (BMSCs) is promising. Indeed, these cells possess interesting properties to modulate CNS environment and allow axon regeneration and functional recovery. Unfortunately, BMSC survival and differentiation within the host spinal cord remain poor, and these cells have been found to have various adverse effects when grafted in other pathological contexts. Moreover, paracrine-mediated actions have been proposed to explain the beneficial effects of BMSC transplantation after spinal cord injury. We thus decided to deliver BMSC-released factors to spinal cord injured rats and to study, in parallel, their properties in vitro. We show that, in vitro, BMSC-conditioned medium (BMSC-CM) protects neurons from apoptosis, activates macrophages and is pro-angiogenic. In vivo, BMSC-CM administered after spinal cord contusion improves motor recovery. Histological analysis confirms the pro-angiogenic action of BMSC-CM, as well as a tissue protection effect. Finally, the characterization of BMSC-CM by cytokine array and ELISA identified trophic factors as well as cytokines likely involved in the beneficial observed effects. In conclusion, our results support the paracrine-mediated mode of action of BMSCs and raise the possibility to develop a cell-free therapeutic approach.

196 citations


"In - Vivo Conversion of Astrocytes ..." refers background in this paper

  • ...MSCs during cell culture can secrete paracrine factors in the form of conditioned medium (CM) (Osugi et al. 2012; Cantinieaux et al. 2013)....

    [...]

  • ...(Cantinieaux et al. 2013; Pawitan 2014)....

    [...]

Frequently Asked Questions (1)
Q1. What have the authors contributed in "In - vivo conversion of astrocytes to neuroblasts in the injured spinal cord" ?

In this paper, Ataei and Karimipour discuss the importance of medical education at Tabriz University of Medical Sciences.